Seattle, WA, United States of America

Taryn Campbell

USPTO Granted Patents = 6 


Average Co-Inventor Count = 16.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Taryn Campbell: Innovator in Pharmaceutical Chemistry

Introduction

Taryn Campbell is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. Her work focuses on developing innovative compounds that address various inflammatory diseases.

Latest Patents

Among her latest patents, Taryn has developed quinoline derivatives, which include a compound of Formula (I) or a pharmaceutically acceptable salt thereof. This patent also encompasses pharmaceutical compositions comprising this compound, processes for preparing it, and therapeutic methods for treating inflammatory diseases. Additionally, she has worked on compounds for the inhibition of α4β7 integrin, which similarly includes a compound of Formula (I) and related pharmaceutical compositions and therapeutic methods.

Career Highlights

Taryn Campbell is currently employed at Gilead Sciences, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key player in the pharmaceutical industry, particularly in the area of treatments for inflammatory conditions.

Collaborations

Throughout her career, Taryn has collaborated with notable colleagues, including Peter A Blomgren and Jayaraman Chandrasekhar. These partnerships have further enhanced her research capabilities and contributed to her success in the field.

Conclusion

Taryn Campbell is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in treating inflammatory diseases. Her contributions through her patents and collaborations highlight her impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…